Mark F. Kubik
Corporate Officer/Principal bij GENOR BIOPHARMA HOLDINGS LIMITED
Actieve functies van Mark F. Kubik
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Corporate Officer/Principal | 17-08-2021 | - |
Loopbaan van Mark F. Kubik
Eerdere bekende functies van Mark F. Kubik
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
OncoImmune, Inc.
 OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - | - |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 03-03-2021 | - |
Opleiding van Mark F. Kubik
| The Leeds School of Business | Masters Business Admin |
| University of Colorado Boulder | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| China | 2 |
Operationeel
| Corporate Officer/Principal | 4 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
OncoImmune, Inc.
OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD. | Health Technology |
- Beurs
- Insiders
- Mark F. Kubik
- Ervaring
